The cytocompatibility and early osteogenic characteristics of an injectable calcium phosphate cement

Tissue Engineering

Volumn 13, Issue 3, 2007, Pages 493-500

  Link, Dennis P ^a   Van Den Dolder, Juliette ^a   Wolke, Joop G C ^a   Jansen, John A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELLS; CELL VIABILITY; CEMENT DISCS; OSTEOGENIC CHARACTERISTICS;

BIOCOMPATIBILITY; BONE CEMENT; CALCIUM PHOSPHATE; DNA; RATS; SCANNING ELECTRON MICROSCOPY;

TISSUE;

ALKALINE PHOSPHATASE; ALPHA TRICALCIUM PHOSPHATE; CALCIUM PHOSPHATE; CEMENT; DNA; HYDROXYAPATITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DEVICE; ENZYME ACTIVITY; EVALUATION; HEAT TREATMENT; HIGH TEMPERATURE; HYDROLYSIS; IMAGE ANALYSIS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; TEMPERATURE DEPENDENCE; TISSUE ENGINEERING; X RAY DIFFRACTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; BONE MARROW CELLS; CALCIUM PHOSPHATES; CELLS, CULTURED; INJECTIONS; MALE; OSTEOGENESIS; RATS; RATS, WISTAR;

RATTUS;

EID: 34147202597     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0015     Document Type: Article

References (42)

1. Mastrogiacomo M, Muraglia A, Komlev V, Peyrin F, Rustichelli F, Crovace A, Cancedda R. Tissue engineering of bone:search for a better scaffold. Orthod Craniofac Res 2005;8:277-84.
2. Ohgushi H, Goldberg V.M., Caplan A.I. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand 1989;60:334-9.
3. Goshima J, Goldberg V.M., Caplan A.I. The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin Orthop Relat Res 1991;298-311.
4. Bruder S.P., Jaiswal N, Ricalton N.S., Mosca J.D., Kraus K.H., Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998;S247-56.
5. Bruder S.P., Kraus K.H., Goldberg V.M., Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;80:985-96.
6. Bruder S.P., Kurth A.A., Shea M, Hayes W.C., Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-62.
7. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 2000;49:328-37.
8. Bruder S.P., Fink D.J., Caplan A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994;56:283-94.
9. Fickert S, Fiedler J, Brenner R.E. Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthritis Cartilage 2003;11:790-800.
10. Gronthos S, Zannettino A.C., Hay S.J., Shi S, Graves S.E., Kortesidis A, Simmons P.J. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-35.
11. Jones E.A., Kinsey S.E., English A, Jones R.A., Straszynski L, Meredith D.M., Markham A.F., Jack A, Emery P, McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002; 46:3349-60.
12. van den Dolder J, Bancroft G.N., Sikavitsas V.I., Spauwen P.H., Jansen J.A., Mikos A.G. Flow perfusion culture of marrow stromal osteoblasts in titanium fiber mesh. J Biomed Mater Res 2003;64A:235-41.
13. Zhao F, Ma T. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol Bioeng 2005;91:482-93.
14. Tanaka S.M., Sun H.B., Roeder R.K., Burr D.B., Turner C.H., Yokota H. Osteoblast responses one hour after load-induced fluid flow in a three-dimensional porous matrix. Calcif Tissue Int 2005;76:261-71.
15. Yu X, Botchwey E.A., Levine E.M., Pollack S.R., Laurencin C.T. Bioreactor-based bone tissue engineering: the influence of dynamic flow on osteoblast phenotypic expression and matrix mineralization. Proc Natl Acad Sci U S A 2004;101:11203-8.
16. Cartmell S.H., Porter B.D., Garcia A.J., Guldberg R.E. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng 2003;9:1197-203.
17. Payne R.G., Yaszemski MJ., Yasko A.W., Mikos A.G. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface cross-linked gelatin microparticles. Biomaterials 2002;23:4359-71.
18. Koch S, Schwinger C, Kressler J, Heinzen Ch., Rainov N.G. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics. J Microencapsul 2003;20:303-16.
19. Liu Z.C., Chang T.M. Increased viability of transplanted hepatocytes when hepatocytes are co-encapsulated with bone marrow stem cells using a novel method. Artif Cells Blood Substit Immobil Biotechnol 2002;30:99-112.
20. Tobias C.A., Han S.S., Shumsky J.S., Kim D, Tumolo M, Dhoot N.O., Wheatley MA, Fischer I, Tessler A, Murray M. Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J Neurotrauma 2005;22:138- 56.
21. del Real R.P., Ooms E, Wolke J.G., Vallet-Regi M, Jansen J.A. In vivo bone response to porous calcium phosphate cement. J Biomed Mater Res 2003;65A:30-6.
22. Ruhe P.Q., Hedberg-Dirk E.L., Padron N.T., Spauwen P.H., Jansen J.A., Mikos A.G. Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 2006;12:789-800.
23. Ruhe P.Q., Hedberg E.L., Padron N.T., Spauwen P.H., Jansen J.A., Mikos A.G. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 2003;85-A Suppl 3:75-81.
24. Ooms E.M., Wolke J.G., van der Waerden J.P., Jansen J.A. Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res 2002;61:9-18.
25. Ooms E.M., Egglezos E.A., Wolke J.G., Jansen J.A. Soft-tissue response to injectable calcium phosphate cements. Biomaterials 2003;24:749-57.
26. del Real R.P., Wolke J.G., Vallet-Regi M, Jansen J.A. A new method to produce macropores in calcium phosphate cements. Biomaterials 2002;23:3673-80.
27. Ruhe P.Q., Hedberg E.L., Padron N.T., Spauwen P.M., Jansen J.A., Mikos A.G. Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 2005;74:533-44.
28. Oreffo R.O., Driessens F.C., Flanell J.A., Triffitt J.T. Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998;19:1845-54.
29. Knabe C, Berger G, Gildenhaar R, Meyer J, Howlett C.R., Markovic B, Zreiqat H. Effect of rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone-related genes and proteins in vitro. J Biomed Mater Res A 2004;69:145-54.
30. Hempel U, Reinstorf A, Poppe M, Fischer U, Gelinsky M, Pompe W, Wenzel KW. Proliferation and differentiation of osteoblasts on Biocement D modified with collagen type I and citric acid. J Biomed Mater Res 2004;71B:130-43.
31. Maniatopoulos C, Sodek J, Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-30.
32. John A, Varma H.K., Kumari T.V. Surface reactivity of calcium phosphate based ceramics in a cell culture system. J Biomater Appl 2003;18:63-78.
33. Langstaff S, Sayer M, Smith T.J., Pugh S.M., Hesp S.A., Thompson W.T. Resorbable bioceramics based on stabilized calcium phosphates. Part I: rational design, sample preparation and material characterization. Biomaterials 1999;20:1727-41.
34. Reid J.W., Pietak A, Sayer M, Dunfield D, Smith T.J. Phase formation and evolution in the silicon substituted tricalcium phosphate/apatite system. Biomaterials 2005;26:2887-97.
35. Knepper-Nicolai B, Reinstorf A, Hofinger I, Flade K, Wenz R, Pompe W. Influence of osteocalcin and collagen I on the mechanical and biological properties of Biocement D. Biomol Eng 2002;19:227-31.
36. Sharpe J.R., Sammons R.L., Marquis P.M. Effect of pH on protein adsorption to hydroxyapatite and tricalcium phosphate ceramics. Biomaterials 1997;18:471-6.
37. Kaysinger K.K., Ramp W.K. Extracellular pH modulates the activity of cultured human osteoblasts. J Cell Biochem 1998;68:83-9.
38. Krieger N.S., Frick K.K., Bushinsky D.A. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 2004;13:423-36.
39. Knabe C, Gildenhaar R, Berger G, Ostapowicz W, Fitzner R, Radlanski R.J., Gross U. Morphological evaluation of osteoblasts cultured on different calcium phosphate ceramics. Biomaterials 1997;18:1339-47.
40. Pioletti D.P., Takei H, Lin T, Van Landuyt P, Ma Q.J., Kwon S.Y., Sung K.L. The effects of calcium phosphate cement particles on osteoblast functions. Biomaterials 2000;21:1103-14.
41. Comuzzi L, Ooms E, Jansen J.A. Injectable calcium phosphate cement as a filler for bone defects around oral implants:an experimental study in goats. Clin Oral Implants Res 2002;13:304-11.
42. Rosengren A, Faxius L, Tanaka N, Watanabe M, Bjursten L.M. Comparison of implantation and cytotoxicity testing for initially toxic biomaterials. J Biomed Mater Res A 2005;75:115-22.